[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366059-105":59,"doc-detail-366059-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","molecular-mechanisms-and-clinical-divergences-in-hpv-positive-cervical-vs-oropharyngeal-cancers-a-critical-narrative-review","Molecular Mechanisms and Clinical Divergences in HPV-Positive Cervical vs. Oropharyngeal Cancers - A Critical Narrative Review","","Human papillomavirus (HPV) is central to both cervical squamous cell carcinoma and oropharyngeal squamous cell carcinoma, yet the two show distinct clinical behavior. HPV-positive OPSCC demonstrates increased radiosensitivity, supporting treatment de-escalation and lower toxicity, whereas HPV-positive CSCC lacks this benefit and requires aggressive therapy similar to HPV-negative disease. This critical narrative review synthesizes known molecular drivers, focusing on HPV E6/E7 effects, DNA integration, genomic instability, and how these processes may shape radiosensitivity and clinical outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/molecular-mechanisms-and-clinical-divergences-in-hpv-positive-cervical-vs-oropharyngeal-cancers-a-critical-narrative-review/366059/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/molecular-mechanisms-and-clinical-divergences-in-hpv-positive-cervical-vs-oropharyngeal-cancers-a-critical-narrative-review/366059.png","ImageObject",300,407,{"name":92,"@type":93},"Putri","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why do HPV-positive OPSCC and HPV-positive CSCC differ clinically?","Question",{"text":112,"@type":113},"Although both cancers share HPV as a viral cause, HPV-positive OPSCC is more radiosensitive, enabling better outcomes, while HPV-positive CSCC does not show increased radiosensitivity and therefore needs aggressive treatment like HPV-negative disease.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What mechanisms does the review emphasize for the divergent responses?",{"text":117,"@type":113},"The review highlights the roles of HPV E6 and E7 oncoproteins, HPV DNA integration into the host genome, and the resulting genomic instability as potential drivers of different clinical behavior.",{"name":119,"@type":110,"acceptedAnswer":120},"How can understanding molecular differences improve patient care?",{"text":121,"@type":113},"Clarifying how molecular pathways influence radiosensitivity in HPV-related cancers can improve treatment strategies, enhance patient outcomes, and reduce treatment-associated toxicity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366059,1790656456,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Martinelli et al. BMC Medicine (2025) 23:405 [https://doi.org/10.1186/s12916-025-04247-z](https://doi.org/10.1186/s12916-025-04247-z)  \nBMC Medicine  \n REVIEW Open Access  \nMolecular Mechanisms and Clinical Divergences in HPV-Positive Cervical vs. Oropharyngeal Cancers: A Critical Narrative Review  \nCanio Martinelli1,2, Alfredo Ercoli 1, Silvana Parisi3, Giuseppe Iatì3, Stefano Pergolizzi3, Luigi Alfano4, Francesca Pentimalli5, Michelino De Laurentiis6*, Antonio Giordano2,7* and Salvatore Cortellino8,9,10*  \nAbstract  \nHuman papillomavirus (HPV) plays a pivotal role in the development of both cervical squamous cell carcinoma (CSCC) and oropharyngeal squamous cell carcinoma (OPSCC) . However, these two cancers exhibit markedly different clinical behaviors. While HPV-positive OPSCC is distinguished by its heightened radiosensitivity, enabling effective treatment de-escalation and reduced toxicity, HPV-positive CSCC shows no such advantage, requiring aggressive therapeutic approaches similar to HPV-negative cases. This critical narrative review explores the limited molecular drivers currently known and the potential mechanisms underlying the divergent clinical responses of HPV-positive OPSCC and CSCC. Here, we discuss the role of HPV E6 and E7 oncoproteins in disrupting key tumor suppressor pathways, the impact of HPV DNA integration into the host genome, and the resulting genomic instability. By comparing the molecular mechanisms of these cancers, we aim to provide a comprehensive understanding of how these processes contribute to their distinct radiosensitivities and clinical outcomes. This review further highlights the gaps in the current research and proposes areas for future investigation, particularly in tailoring personalized treatment strategies for HPV-driven cancers. Understanding the differences in the molecular pathways that influence radiosensitivity in HPV-related cancers will not only enhance treatment strategies but also lead to improved patient outcomes and reduced treatmentassociated toxicity.  \nKeywords Human papillomavirus, Cervical cancer, Oropharyngeal cancer, Molecular oncology, Radiosensitivity  \n*Correspondence:  \nMichelino De Laurentiis [m.delaurentiis@istitutotumori. na.it](m.delaurentiis@istitutotumori. na.it)[ ](m.delaurentiis@istitutotumori. na.it)Antonio Giordano  \n[giordano@temple.edu](giordano@temple.edu); [giordano12@unisi.it](giordano12@unisi.it)[ ](giordano12@unisi.it)Salvatore Cortellino[s.cortellino@ssmeridionale.it](s.cortellino@ssmeridionale.it)  \n1 Unit of Gynecology and Obstetrics, Department of Human Pathology of Adults and Developmental Age, G, Martino University Hospital, Messina, Italy  \n2 Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA  \n3 Radiation Oncology Unit, Department of Biomedical, Dental Science and Morphological and Functional Images, University of Messina, Messina, Italy  \n4 Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori -IRCCSFondazione G. Pascale, Naples, Italy  \n5 Department of Medicine and Surgery, LUM University Giuseppe De Gennaro, Casamassima, Bari, Italy  \n6 Division of Breast Medical Oncology, Istituto Nazionale Tumori -IRCCSFondazione G. Pascale, Naples, Italy  \n7 Department of Medical Biotechnologies, University of Siena,  \n53100 Siena, Italy  \n8 Laboratory of Molecular Oncology, Responsible Research Hospital, Campobasso, Italy  \n9 Clinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy  \n10 SHRO Italia Foundation ETS, Candiolo, Turin, Italy  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes w","cbCaiorKQ5RJMWq6","https://ap.wps.com/l/cbCaiorKQ5RJMWq6","pdf",1475766,18,"English","# Abstract\n# Background\n## Epidemiology and HPV Genotypes\n## Divergent Clinical Behavior and Treatment Response","[{\"question\":\"Why do HPV-positive OPSCC and HPV-positive CSCC differ clinically?\",\"answer\":\"Although both cancers share HPV as a viral cause, HPV-positive OPSCC is more radiosensitive, enabling better outcomes, while HPV-positive CSCC does not show increased radiosensitivity and therefore needs aggressive treatment like HPV-negative disease.\"},{\"question\":\"What mechanisms does the review emphasize for the divergent responses?\",\"answer\":\"The review highlights the roles of HPV E6 and E7 oncoproteins, HPV DNA integration into the host genome, and the resulting genomic instability as potential drivers of different clinical behavior.\"},{\"question\":\"How can understanding molecular differences improve patient care?\",\"answer\":\"Clarifying how molecular pathways influence radiosensitivity in HPV-related cancers can improve treatment strategies, enhance patient outcomes, and reduce treatment-associated toxicity.\"}]","Molecular Mechanisms and Clinical Divergences in HPV-Positive Cervical vs. Oropharyngeal Cancers - A Critical Narrative Review | PDF",1790163716,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9a5aab7ebdc351bc3d1025162084dcd.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/947f49a6a63611aabace210551531179.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9780e34c41dfdb2e36e70cfd112d1d11.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4662994ce6a9b65d9e5098d0a338023a.webp",980,1301]